Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Paul, Fitzmorris"'
Autor:
Shajan Peter, Adam L. Edwards, Charles M. Wilcox, James F. George, Salpy V. Pamboukian, Paul Fitzmorris
Publikováno v:
ASAIO Journal. 64:472-479
Gastrointestinal bleeding (GIB) is common in patients with continuous-flow left ventricular assist devices (CF-LVADs) possibly because of changes in blood flow. We aimed to test the hypothesis that a low pulsatility index (PI) is associated with an i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5348e3df3adb2b35bad70bbd323cf63
https://doi.org/10.1097/mat.0000000000000766
https://doi.org/10.1097/mat.0000000000000766
Autor:
Yuqi Guo, Vishnu Kommineni, Omar T. Sims, John Romano, Krishna Venkata, Paul Fitzmorris, Mohamed Shoreibah, Omar Massoud
Publikováno v:
European Journal of Gastroenterology & Hepatology. 29:1219-1222
ObjectiveDirect acting antivirals (DAAs) have overcome many long-standing medical barriers to hepatitis C virus (HCV) treatment (i.e. host characteristics and medical contraindications) and treatment outcome disparities that were associated with inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f24a947976556525c8af4b5929e365da
https://doi.org/10.1097/meg.0000000000000961
https://doi.org/10.1097/meg.0000000000000961
Autor:
Jordan Orr, DeAnn Jones, Vishnu Kommineni, Mohamed Shoreibah, John Romano, Krishna Venkata, Omar Massoud, Omar T. Sims, Yuqi Guo, Paul Fitzmorris
Publikováno v:
Journal of Clinical and Translational Hepatology
Background and Aims: Hepatitis C Virus (HCV) is uniformly recurrent after liver transplant (LT) and recurrence is associated with an increased risk of mortality. Immunosuppressive medications increase the risk of chronic kidney disease, and the prese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e1d670e10e0fff0917b17f6b8b544a6
https://pubmed.ncbi.nlm.nih.gov/30637216
https://pubmed.ncbi.nlm.nih.gov/30637216
Autor:
Caroline Walker, Talha A. Malik, Paul Fitzmorris, Jordan Orr, Fenglong Xie, Chaitanya Allamneni, Huifeng Yun
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-6 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-6 (2018)
Racial disparities are observed clinically in Crohn’s Disease (CD) with research suggesting African Americans (AA) have worse outcomes than Caucasian Americans (CA). The aim of this study is to assess whether socioeconomic status (SES) rather than
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::903ab2c167b51a45ca03f1c4dfb83d18
https://doi.org/10.1038/s41598-018-22429-z
https://doi.org/10.1038/s41598-018-22429-z
Autor:
Omar T, Sims, Yuqi, Guo, Mohamed G, Shoreibah, Krishna, Venkata, Paul, Fitzmorris, Vishnu, Kommineni, John, Romano, Omar I, Massoud
Publikováno v:
European journal of gastroenterologyhepatology. 29(11)
Direct acting antivirals (DAAs) have overcome many long-standing medical barriers to hepatitis C virus (HCV) treatment (i.e. host characteristics and medical contraindications) and treatment outcome disparities that were associated with interferon re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::27b0108a327c4e33954a1775a41eeb65
https://pubmed.ncbi.nlm.nih.gov/28857899
https://pubmed.ncbi.nlm.nih.gov/28857899
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 141:861-876
Hepatocellular carcinoma (HCC), a common cause for cancer-related death, is increasing worldwide. Over the past decade, survival and quality of life of HCC patients have significantly improved due to better prevention strategies, early diagnosis, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6bcdaf0b5b1a275dc03ab87c786a03b
https://doi.org/10.1007/s00432-014-1806-0
https://doi.org/10.1007/s00432-014-1806-0
Autor:
Paul, Fitzmorris, Ashwani K, Singal
Publikováno v:
Gastroenterologyhepatology. 11(1)
Hepatocellular carcinoma (HCC) is an important cause of cancer-related death worldwide. If the disease is detected early, the treatment is more likely to be curative. This article discusses the current evidence regarding the surveillance and diagnosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3dfadf8d37d22c8fa9530db514dd3e67
https://pubmed.ncbi.nlm.nih.gov/27099571
https://pubmed.ncbi.nlm.nih.gov/27099571
Autor:
Yong Fang Kuo, Paul Fitzmorris, Anupam Agarwal, Toni Seay, Kirk Russ, Bradford E. Jackson, Sumant Arora, Ashwani K. Singal, Karan Singh, Donny Kakati, Glauber B. Pereira
Publikováno v:
Gastroenterology. 152:S1132
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e0f7380a1529efb1d0177e6f05135ac
https://doi.org/10.1016/s0016-5085(17)33807-6
https://doi.org/10.1016/s0016-5085(17)33807-6
Autor:
Ioana Smith, Donny Kakati, Talha A. Malik, Lisandro D. Colantonio, Euriko G. Torrazza Perez, Paul Fitzmorris
Publikováno v:
Digestion. 91(3)
Background/Aims: Recent studies suggest that markers of mesenteric inflammation, such as increased adipose tissue, may be associated with poor outcomes in Crohn's disease (CD). This study's hypothesis is that CD patients with metabolic syndrome (MetS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49049433824a1ce2404f8168939d6294
https://pubmed.ncbi.nlm.nih.gov/25833139
https://pubmed.ncbi.nlm.nih.gov/25833139
Publikováno v:
Gastroenterology. 148(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa6907efea3b6a2de37e2c253033c24a
https://pubmed.ncbi.nlm.nih.gov/25622788
https://pubmed.ncbi.nlm.nih.gov/25622788